The clinical values of dysregulated DNA methylation and demethylation intermediates in acute lymphoblastic leukemia.

Conclusion: This study described a novel role for global methylation and demethylation intermediates in ALL detection and prognosis, and provided new clue to distinguish high-risk patients and improve the curative effect on ALL patients. PMID: 31315520 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31315520?dopt=Abstract

Source: Hematology - July 20, 2019 Category: Hematology Tags: Hematology Source Type: research